Skip to main content
Top
Published in:

01-07-2024 | Teratoma | Mini Review

Congenital orbital teratoma: a rare case with intracranial extension

Authors: Clara Magalhães Paiva, Maristella Reis da Costa Pereira, Antônio Rosa Bellas, Tatiana Protzenko

Published in: Child's Nervous System | Issue 9/2024

Login to get access

Abstract

Introduction

Teratoma is the most common congenital tumor, but the orbital location is rare. It is composed of tissues from ectoderm, mesoderm, and endoderm.

Clinical presentation

Congenital orbital teratoma commonly presents as unilateral proptosis, with rapid growth, leading to exposure keratopathy.

Diagnosis

Prenatal ultrasound may detect the orbital mass, computed tomography (CT) scans, and magnetic resonance (MR) imaging are better in demonstrating multilocular cystic and solid mass, without bone erosion. Laboratory tests should include alfa-fetoprotein (AFP) and B-human chorionic gonadotropin (B-HCG), and histopathologically, it contains all three germ cell layers components. The management is surgical removal of the lesion, the mature teratoma has a benign behavior, and the immature has a poor prognostic. We describe a rare case of congenital orbital teratoma with intracranial extension of the lesion, in which was treated with orbital exenteration. After surgery, AFP levels decreased, the middle face displacement has improved and development milestones were appropriate.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Congenital orbital teratoma: a rare case with intracranial extension
Authors
Clara Magalhães Paiva
Maristella Reis da Costa Pereira
Antônio Rosa Bellas
Tatiana Protzenko
Publication date
01-07-2024
Publisher
Springer Berlin Heidelberg
Keyword
Teratoma
Published in
Child's Nervous System / Issue 9/2024
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-024-06510-9

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest